二氢杨梅素

Dihydromyricetin

未知生产厂商

Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus).

技术标识符

化学式: C₁₅H₁₂O₈
CAS 编号: 27200-12-0
UNII ID: KD8QND6427

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

COSMETIC COMPOSITION COMPRISING DIHYDROMYRICETIN
WO 2025227307 A1申请人: BEIERSDORF AG优先权: 2024
CN
WO
3 件公开
Racemic dihydromyricetin monohydrate crystal
CN 106008439 A申请人: AFFILIATED TONGJI HOSPITAL OF TONGJI MEDICAL COLLEGE OF HUAZHONG UNIV OF SCIENCE & TECH优先权: 2014
CN
3 件公开
(USE OF MYRICETIN AND DIHYDROMYRICETIN PHOSPHATE COMPOUND IN DRUG FOR PREVENTING AND TREATING COVID-19)
WO 2022184102 A1申请人: SHANGHAI INST MATERIA MEDICA CAS优先权: 2021
CN
WO
2 件公开
Dihydromyricetin nanocrystals and preparation method and application thereof
US 11834428 B2申请人: UNIV SHAANXI SCIENCE & TECH优先权: 2022
CN
US
2 件公开
DIHYDROMYRICETIN AND POLAR OILS
WO 2024256102 A1申请人: BEIERSDORF AG优先权: 2023
EP
WO
2 件公开
DIHYDROMYRICETIN AND SULFITES
WO 2025021355 A1申请人: BEIERSDORF AG优先权: 2023
EP
WO
2 件公开
DIHYDROMYRICETIN-BASED NITROGEN-CONTAINING DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
WO 2025156317 A1申请人: UNIV GUANGDONG OCEAN优先权: 2024
CN
WO
2 件公开
Novel application of dihydromyricetin
- CN 114053263 A
  申请人: GUOKE TESHAN JIANGSU BIOTECHNOLOGY CO LTD优先权: 2021
  CN
  2 件公开
- CN 108567772 A
  申请人: UNIV GUANGXI NORMAL优先权: 2018
  CN
Synthetic method of dihydromyricetin
CN 116514759 A申请人: UNIV HUAZHONG AGRICULTURAL优先权: 2022
CN
2 件公开
Method for purifying dihydromyricetin
CN 101824018 B申请人: UNIV HANSHAN NORMAL优先权: 2010
CN

药物

二氢杨梅素

概览

专利

Novel application of dihydromyricetin